000			01766 a2200493 4500
005			20250513100323.0
264		0	_c19961203
008			199612s 0 0 eng d
022			_a0031-3998
024	7		_a10.1203/00006450-199607000-00022 _2doi
040			_aNLM _beng _cNLM
100	1		_aWinklhofer-Roob, B M
245	0	0	_aNeutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation. _h[electronic resource]
260			_bPediatric research _cJul 1996
300			_a130-4 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntioxidants _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCystic Fibrosis _xblood
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLeukocyte Elastase _xantagonists & inhibitors
650	0	4	_aLipid Peroxidation _xdrug effects
650	0	4	_aLipid Peroxides _xblood
650	0	4	_aMale
650	0	4	_aNeutrophils _xenzymology
650	0	4	_aPancreatic Elastase _xantagonists & inhibitors
650	0	4	_aSerine Proteinase Inhibitors _xblood
650	0	4	_aVitamin E _xblood
650	0	4	_aalpha 1-Antitrypsin _xmetabolism
650	0	4	_abeta Carotene _xtherapeutic use
700	1		_aSchlegel-Haueter, S E
700	1		_aKhoschsorur, G
700	1		_avan't Hof, M A
700	1		_aSuter, S
700	1		_aShmerling, D H
773	0		_tPediatric research _gvol. 40 _gno. 1 _gp. 130-4
856	4	0	_uhttps://doi.org/10.1203/00006450-199607000-00022 _zAvailable from publisher's website
999			_c8794559 _d8794559